<DOC>
	<DOCNO>NCT00311779</DOCNO>
	<brief_summary>The primary objective study determine safety efficacy different strength Spinosad topical creme , compare vehicle control , subject infest least mild case Pediculosis capitis ( head louse ) .</brief_summary>
	<brief_title>A Dose Ranging Study Different Strengths Spinosad Topical Creme Subjects With Pediculosis Capitis</brief_title>
	<detailed_description>There million child adult affect head louse year United States . It become major nuisance school child result many lose school day frustrate parent . Lice nit ( ovum ) resistance current OTC product report . Compliance product instruction think low . Therefore safe effective alternative product desirable . Spinosad formulation approve Environmental Protection Agency crop protection product US , Canada Australia , receive provisional approval UK , Spain several European Union country . Spinosad formulate creme rinse use excipients widely use `` generally regarded safe '' ( GRAS ) . This study intend show safety efficacy Spinosad 0.5 % 1.0 % , compare vehicle control subject 2 year age old least mild infestation pediculosis capitis .</detailed_description>
	<mesh_term>Lice Infestations</mesh_term>
	<criteria>1 . Subject must head lice infestation least mild severity present baseline least 3 live louse presence nit ; 2 . Subject either male female , 2 year old 3 . Subject must good general health , base medical history . 4 . Each subject must appropriately sign informed consent . 5 . The parent guardian child subject must willing allow household member screen head louse . If household member find head lice infestation , also enrol study . If household member willing enroll study qualify enrollment , must willing use standard course OTC louse treatment home . 6 . Subjects must agree use form louse treatment course study . Subjects must also agree use louse comb course study . 7 . Subjects must agree cut chemically treat hair period Baseline treatment Day 14 visit . 1 . Individuals history irritation sensitivity pediculicides hair care product . 2 . Individuals visible skin/scalp condition treatment site , opinion investigative personnel , interfere evaluation . 3 . Individuals previously treat pediculicide within 4 week prior study . 4 . Individuals use hair dye , bleach , permanent wave relax solution within past 2 week study . 5 . Individuals condition illness , opinion investigator , may compromise objective protocol . 6 . Individuals receive systemic topical drug medication , include systemic antibiotic , opinion investigative personnel may interfere study result . 7 . Individuals participate clinical trial within past 30 day . 8 . Individuals , opinion investigator , understand subject requirement study participation and/or may likely exhibit poor compliance . 9 . Individuals family member infest lice unwilling unable enroll study ouse standard course louse treatment . 10 . Females pregnant nursing . 11 . Sexually active female use effective contraception . 12 . Individuals history drug abuse past year .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Pediculosis capitis</keyword>
	<keyword>Head Lice</keyword>
	<keyword>Crawlers</keyword>
	<keyword>Ova</keyword>
</DOC>